Thirteen years of antibiotic susceptibility surveillance of Pseudomonas aeruginosa from intensive care units and urology services in the Netherlands

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 2, 2013, Pages 283-288

  Croughs, P D ^a,b   Li, B ^b   Hoogkamp Korstanje, J A A ^a   Stobberingh, E ^a,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; ESCHERICHIA COLI; HOSPITAL DEPARTMENT; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NETHERLANDS; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TREND STUDY;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; NETHERLANDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; UROLOGY DEPARTMENT, HOSPITAL;

EID: 84872609971     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1741-4     Document Type: Article

References (23)

1. Kahlmeter G (2000) The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens - interim report. J Antimicrob Chemother 46(Suppl 1):15-22
2. SWAB, NethMap (2003) Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. SWAB, Bilthoven
3. Gaynes R, Edwards JR; National Nosocomial Infections Surveillance System (2005) Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41(6):848-854
4. Bouza E, San Juan R, Muñoz P et al (2001) A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection. Clin Microbiol Infect 7(10):532-542
5. Johansen TE, Cek M, Naber KG et al (2006) Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies. Int J Antimicrob Agents 28(Suppl 1):S91-S107
6. European Antimicrobial Resistance Surveillance Network (EARS-Net). EARSS Annual reports. Home page at: http://www.rivm.nl/earss/
7. Miriagou V, Cornaglia G, Edelstein M et al (2010) Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 16(2):112-122
8. Lister PD, Wolter DJ, Hanson ND (2009) Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22(4):582-610
9. Livermore DM (1992) Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 36(9):2046-2048
10. Pitout JD, Chow BL, Gregson DB et al (2007) Molecular epidemiology of metallo-β-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing Isolates. J Clin Microbiol 45(2):294-298
11. Jacquier H, Le Monnier A, Carbonnelle E et al (2012) In vitro antimicrobial activity of "last-resort" antibiotics against unusual nonfermenting gram-negative bacilli clinical isolates. Microb Drug Resist 18(4):396-401
12. Dinh A, Salomon J, Bru JP et al (2012) Fosfomycin: efficacy against infections caused by multidrug-resistant bacteria. Scand J Infect Dis 44(3):182-189
13. SWAB, NethMap (2005) Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. SWAB, Bilthoven
14. SWAB, NethMap (2010) Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. SWAB, Bilthoven
15. SWAB, NethMap (2011) Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. SWAB, Bilthoven
16. Yakupogullari Y, Otlu B, Dogukan M et al (2008) Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa. Am J Infect Control 36(10):e13-e18
17. Van der Bij AK, Van der Zwan D, Peirano G et al (2012) Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type. Clin Microbiol Infect 18(9):E369-E372
18. Quinteira S, Sousa JC, Peixe L (2005) Characterization of In100, a new integron carrying a metallo-β-lactamase and a carbenicillinase, from Pseudomonas aeruginosa. Antimicrob Agents Chemother 49(1):451-453
19. Fukuda H, Hosaka M, Hirai K et al (1990) New norfloxacin resistance gene in Pseudomonas aeruginosa PAO. Antimicrob Agents Chemother 34(9):1757-1761
20. Aubert G, Pozzetto B, Dorche G (1992) Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy. J Antimicrob Chemother 29(3):307-312
21. Livermore DM (2002) Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34:634-640
22. Deplano A, Denis O, Poirel L et al (2005) Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol 43(3):1198-1204
23. Paul M, Shani V, Muchtar E et al (2010) Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 54(11):4851-4863